Abstract
Vitamin C (ascorbic acid, ascorbate) has a controversial history in cancer treatment. Emerging evidence indicates that ascorbate in cancer treatment deserves re-examination. As research results concerning ascorbate pharmacokinetics and its mechanisms of action against tumor cells have been published, and as evidence from case studies has continued to mount that ascorbate therapy could be effective if the right protocols were used, interest among physicians and scientists has increased. In this review, high-dose vitamin C therapy in cancer treatment is re-evaluated.
- Cancer
- vitamin C
- ascorbic acid
- ascorbate
- plasma concentration
- intravenous
- cytotoxicity
- complementary and alternative medicine
- review
- Received May 28, 2008.
- Revision received July 31, 2008.
- Accepted August 18, 2008.
- Copyright© 2009 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved